VERV

Verve Therapeutics
VERV

Overview Fund Activity
Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

125 hedge funds and large institutions have $2.08B invested in Verve Therapeutics in 2022 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 55 increasing their positions, 16 reducing their positions, and 21 closing their positions.

Holders
125
Holders Change
+24
Holders Change %
+23.76%
% of All Funds
2.16%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
45
Increased
55
Reduced
16
Closed
21
Calls
$16M
Puts
$4.26M
Net Calls
+$11.7M
Net Calls Change
+$8.05M

Top Buyers

1
State Street
1
State Street
Massachusetts
$96.2M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$257M
3
AIM
3
ARK Investment Management
Florida
$117M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$126M
5
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$43.1M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$2.43M
2
AVM
2
Arch Venture Management
Illinois
$69M
3
RG
3
Redmile Group
California
$51.7M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$34.7M
5
Millennium Management
5
Millennium Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
AI
1
Alphabet Inc
California
$377M 10,974,011 – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$257M 7,482,350 +2,166,571 +41%
Vanguard Group
3
Vanguard Group
Pennsylvania
$126M 3,658,812 +1,316,619 +56%
AIM
4
ARK Investment Management
Florida
$117M 3,393,859 +1,359,735 +67%
BlackRock
5
BlackRock
New York
$116M 3,376,210 +792,139 +31%
CC
6
Casdin Capital
New York
$109M 3,178,167 +40,000 +1%
State Street
7
State Street
Massachusetts
$96.2M 2,799,834 +2,194,551 +363%
AVM
8
Arch Venture Management
Illinois
$69M 2,008,809 -500,000 -20%
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$65.9M 1,918,490 +563,852 +42%
Federated Hermes
10
Federated Hermes
Pennsylvania
$60.1M 1,749,737 +651,900 +59%
RG
11
Redmile Group
California
$51.7M 1,505,126 -328,421 -18%
BBA
12
Baker Bros. Advisors
New York
$48.7M 1,416,530 – –
T. Rowe Price Investment Management
13
T. Rowe Price Investment Management
Maryland
$43.1M 1,254,816 +1,254,816 New
PHS
14
PFM Health Sciences
California
$40.1M 1,168,808 +323,622 +38%
APM
15
Avidity Partners Management
Texas
$35.8M 1,042,706 +1,042,706 New
Wellington Management Group
16
Wellington Management Group
Massachusetts
$34.7M 1,010,708 -252,676 -20%
NHAS
17
Novo Holdings A/S
Denmark
$31.3M 911,111 -15,989 -2%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$26.9M 782,712 +315,492 +68%
Sumitomo Mitsui Trust Group
19
Sumitomo Mitsui Trust Group
Japan
$26.6M 775,697 +660,465 +573%
DTC
20
Deep Track Capital
Connecticut
$26.6M 775,000 +775,000 New
DM
21
Deerfield Management
New York
$25.8M 750,000 +750,000 New
NAMA
22
Nikko Asset Management Americas
New York
$24.4M 775,697 +660,465 +573%
BI
23
BVF Inc
California
$22.3M 650,000 +650,000 New
MB
24
MPM BioImpact
Massachusetts
$21.8M 635,792 +635,792 New
CAM
25
Cormorant Asset Management
Massachusetts
$20.6M 600,000 -100,710 -14%
1
2 3 4 5